SpringWorks CareConnections® for HCPs

SpringWorks CareConnections provides personalized support services and resources to help your patients start and stay on track with OGSIVEO® (nirogacestat).

Begin Enrollment

Financial Assistance & Insurance Navigation

We’ll help navigate coverage and connect your patients to financial assistance options that may be available.

Your eligible patients with commercial insurance may pay as little as a $0 copay for OGSIVEO.*

Learn More

Ordering Information

OGSIVEO is available through a limited Specialty Pharmacy network or through one of our Specialty Distributor partners.

Learn More

Resources & Forms

Downloadable resources and tools for you and your office staff to further support your patients.

Learn More

Patients enrolled in SpringWorks CareConnections are more likely to stay on treatment1

Have Questions?

Call SpringWorks
CareConnections today

844-CARES-55

(844-227-3755)

Monday-Friday
8 AM-8 PM ET

Field Access
Manager (FAM) Support

For questions about patient access to
OGSIVEO, click to connect with a FAM

Arrow

*Terms and conditions apply. Copay program is subject to an annual benefit maximum. Full terms and conditions provided during the enrollment process and are available upon request by contacting SpringWorks CareConnections at 844-CARES-55 (844-227-3755).

Reference: 1. Zuckerman AD, Renfro CP, Bryan D, et al. Putting patients first: Frontline insights on designing and administering manufacturer patient financial support programs. Am J Health Syst Pharm. 2026;83(9):e363-e369.

© 2026 Merck KGaA, Darmstadt, Germany and/or its affiliates. All rights reserved.

OGSIVEO, GOMEKLI, PIMJETMI, and SpringWorks CareConnections are registered trademarks of Merck KGaA, Darmstadt, Germany and/or its affiliates. All other trademarks are the property of their respective owners.

EMD Serono, Inc. and SpringWorks Therapeutics, Inc. are healthcare companies of Merck KGaA, Darmstadt, Germany.

US-OGS-01037  10/26

This site is intended for U.S. audiences only.

This site is intended for U.S. audiences only.

Cookie Settings